Literature DB >> 22573299

Small hypervascular hepatocellular carcinomas: value of diffusion-weighted imaging compared with "washout" appearance on dynamic MRI.

D J Kim1, J-S Yu, J H Kim, J-J Chung, K W Kim.   

Abstract

OBJECTIVE: To compare the value of diffusion-weighted MRI (DWI) with the venous "washout" appearance during dynamic MRI for the assessment of small arterial hypervascular lesions in cirrhotic liver.
METHODS: After exclusion of benign hypervascular lesions, including haemangiomas and subcapsular non-tumorous arterioportal shunts, indicated by typical imaging features, a total of 109 small arterial hypervascular lesions (0.5-3.0 cm in the longest diameter) in 65 patients with cirrhosis who underwent gadopentetate dimeglumine-enhanced dynamic MRI and DWI (b=50, 400, 800 s mm(-2)) at 1.5 T during a 16-month period were retrospectively analysed to determine the presence of venous washout during dynamic imaging or sustained hyperintensity upon increasing the b factor size on DWI.
RESULTS: Among the 99 hypervascular hepatocellular carcinomas (HCCs), sustained hyperintensity on DWI (92/99, 93%) was more prevalent than the washout appearance (72/99, 72%) on dynamic MRI (p<0.001). Depending on the lesion size, subcentimetre-sized HCCs had a significantly lower prevalence of venous washout (13/30, 43%) than the sustained hyperintensity on DWI (27/30, 90%) (p=0.001). In all 10 hypervascular benign conditions, there was no venous washout on dynamic MRI and no sustained hyperintensity on DWI. Sensitivity and specificity for diagnosis of hypervascular HCCs were 92.9% and 100% in DWI and 72% and 100% in dynamic MRI, respectively.
CONCLUSION: Compared with the venous washout during dynamic imaging, DWI provides more reliable information in the MRI assessment of small hypervascular HCCs, distinguishing them from atypical hypervascular benign or pseudolesions. DWI could complement the early diagnosis of small hypervascular HCCs that do not display venous washout during dynamic imaging.

Entities:  

Mesh:

Year:  2012        PMID: 22573299      PMCID: PMC3474029          DOI: 10.1259/bjr/23975164

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  35 in total

1.  MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.

Authors:  Indra C van den Bos; Shahid M Hussain; Roy S Dwarkasing; Wim C J Hop; Pieter E Zondervan; Robert A de Man; Jan N M IJzermans; Craig W Walker; Gabriel P Krestin
Journal:  J Magn Reson Imaging       Date:  2007-12       Impact factor: 4.813

2.  Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.

Authors:  Bachir Taouli; Anuj J Tolia; Mariela Losada; James S Babb; Edwin S Chan; Michael A Bannan; Hillel Tobias
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

3.  Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions.

Authors:  Christoph J Zech; Karin A Herrmann; Olaf Dietrich; Wilhelm Horger; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2008-04       Impact factor: 6.016

4.  Added diagnostic value of T2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas.

Authors:  Young Kon Kim; Young Hwan Lee; Chong Soo Kim; Young Min Han
Journal:  Eur J Radiol       Date:  2007-08-21       Impact factor: 3.528

5.  Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions.

Authors:  Bachir Taouli; Alison Sandberg; Alto Stemmer; Tejas Parikh; Samson Wong; Jian Xu; Vivian S Lee
Journal:  J Magn Reson Imaging       Date:  2009-09       Impact factor: 4.813

6.  Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions.

Authors:  Naoto Koike; Akihiro Cho; Katsuhiro Nasu; Kazuhiko Seto; Shigeyuki Nagaya; Yuji Ohshima; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

Review 7.  Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.

Authors:  Thomas C Kwee; Taro Takahara; Reiji Ochiai; Rutger A J Nievelstein; Peter R Luijten
Journal:  Eur Radiol       Date:  2008-04-30       Impact factor: 5.315

8.  Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.

Authors:  J S Yu; J H Lee; J J Chung; J H Kim; K W Kim
Journal:  Acta Radiol       Date:  2008-09       Impact factor: 1.990

9.  Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.

Authors:  Tejas Parikh; Stephen J Drew; Vivian S Lee; Samson Wong; Elizabeth M Hecht; James S Babb; Bachir Taouli
Journal:  Radiology       Date:  2008-01-25       Impact factor: 11.105

10.  Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.

Authors:  Peng-Ju Xu; Fu-Hua Yan; Jian-Hua Wang; Jiang Lin; Yuan Ji
Journal:  J Magn Reson Imaging       Date:  2009-02       Impact factor: 4.813

View more
  5 in total

1.  Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings.

Authors:  Michele Di Martino; Luca Saba; Sandro Bosco; Massimo Rossi; Kirchin A Miles; Rossella Di Miscio; Concetta Valentina Lombardo; Elisabetta Tamponi; Mario Piga; Carlo Catalano
Journal:  Eur Radiol       Date:  2014-04-26       Impact factor: 5.315

Review 2.  Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Tin Nadarevic; Agostino Colli; Vanja Giljaca; Mirella Fraquelli; Giovanni Casazza; Cristina Manzotti; Davor Štimac; Damir Miletic
Journal:  Cochrane Database Syst Rev       Date:  2022-05-06

Review 3.  Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma.

Authors:  C G Cristea; I A Gheonea; L D Săndulescu; D I Gheonea; T Ciurea; M R Purcarea
Journal:  J Med Life       Date:  2015 Apr-Jun

4.  Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).

Authors:  Jae Seok Bae; Jung Hoon Kim; Mi Hye Yu; Dong Ho Lee; Hyo-Cheol Kim; Jin Wook Chung; Joon Koo Han
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

Review 5.  Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques.

Authors:  Rajpaul Attariwala; Wayne Picker
Journal:  J Magn Reson Imaging       Date:  2013-08       Impact factor: 4.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.